spacer
home > epc > spring 2009 > regulatory risk
PUBLICATIONS
European Pharmaceutical Contractor

Regulatory Risk

As big pharma continually struggles to identify the right strategy in order to satisfy the marketplace demands and deliver expected financial returns, one area that will always remain a priority is the business obligation to patient safety. Managing the regulatory requirement for any pharmaceutical business is a costly process, but one that cannot easily be ignored. As companies continually strive to cut costs, mostly in the form of employee cutbacks, they have to remain totally committed to satisfying the various regulatory authorities’ compliance requirements and, as this can be a resource-hungry exercise, having fewer employees can introduce some risk into their business. Managing this risk is also the key to controlling cost, and companies should have annual key strategic objectives based around how they will successfully control and improve their compliance performance, as the ever changing demands create new and often more difficult challenges.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

Brian Szukala is Managing Director of SeerPharma (UK) Ltd, a global training auditing and consultancy business. Brian was previously Head of Training at Pfizer and Abbott Laboratories in the UK, and has been actively involved in developing competence and competency frameworks incorporated into performance management systems. He has worked with various government bodies to advise on UK skills issues within the industry and is currently on the strategic board of SEMTA (Sector Skills Council representing pharmaceuticals) advising on skills and UK competitiveness. He has a wealth of experience in the field of compliance and has presented at numerous seminars, both in the UK and abroad on various compliance, behavioural and productivity improvement topics.

spacer
Brian Szukala
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Introducing Signant Health [Formerly CRF Bracket] and the Industry’s Most Comprehensive Patient-Centric Suite for Clinical Research

Philadelphia and London – June 10, 2019: CRF Bracket, formed by the 2018 merger of CRF Health and Bracket, today launched as Signant Health (signanthealth.com). Uniting eCOA, eConsent, Patient Engagement, IRT, Clinical Supplies and Endpoint Quality into the industry’s most comprehensive patient-centric suite, Signant makes it easier to participate in – and sites and study teams to run – clinical trials. This intense focus on the patient experience, deep therapeutic area expertise and global operational scale enable sponsors and CROs to extend the reach of drug development, expand patient opportunities and improve data quality.
More info >>

White Papers

Achieve full compliance with tamper-verification pharma solutions

UPM Raflatac

UPM Raflatac has developed a range of pharmaceutical labelling products to support compliance with the Falsified Medicines Directive on packaging for prescription drugs and high-risk, over-the-counter medicines. Few solutions offer the same ease of adoption for meeting the February 2019 deadline.
More info >>

 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement